The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Current status of the molecular mechanisms of anticancer drug-induced apoptosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289
Thornberry, N. A., & Lazebnik, Y. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,887
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
The Bcl-2 Protein Family: Arbiters of Cell Survival
Adams, J. M., & Cory, S. (1998) · Science · doi:10.1126/science.281.5381.1322 · Cited by 5,332
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T.-I., Jones, D. P., & Wang, X. (1997) · Science · doi:10.1126/science.275.5303.1129 · Cited by 4,911
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy-Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,714
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
Wei, M. C., Zong, W.-X., Cheng, E. H.-Y., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., & Korsmeyer, S. J. (2001) · Science · doi:10.1126/science.1059108 · Cited by 3,988
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
Ambrosini, G., Adida, C., & Altieri, D. C. (1997) · Nature Medicine · doi:10.1038/nm0897-917 · Cited by 3,165
Zha, J., Harada, H., Yang, E., Jockel, J., & Korsmeyer, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81382-3 · Cited by 2,595
Boldin, M. P., Goncharov, T. M., Goltseve, Y. V., & Wallach, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81265-9 · Cited by 2,292
Shimizu, S., Narita, M., Tsujimoto, Y., & Tsujimoto, Y. (1999) · Nature · doi:10.1038/20959 · Cited by 2,178
Control of apoptosis and mitotic spindle checkpoint by survivin
Li, F., Ambrosini, G., Chu, E. Y., Plescia, J., Tognin, S., Marchisio, P. C., & Altieri, D. C. (1998) · Nature · doi:10.1038/25141 · Cited by 1,870
BCL-2 FAMILY: Regulators of Cell Death
Chao, D. T., & Korsmeyer, S. J. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.395 · Cited by 1,685
A Matter of Life and Cell Death
Evan, G., & Littlewood, T. (1998) · Science · doi:10.1126/science.281.5381.1317 · Cited by 1,523
Bcl-xL Regulates the Membrane Potential and Volume Homeostasis of Mitochondria
Vander Heiden, M. G., Chandel, N. S., Williamson, E. K., Schumacker, P. T., & Thompson, C. B. (1997) · Cell · doi:10.1016/s0092-8674(00)80450-x · Cited by 1,378
Tamm, I., Wang, Y., Sausville, E. A., Scudiero, D. A., Vigna, N. J., Oltersdorf, T., & Reed, J. C. (1998) · PubMed · Cited by 1,244
Green, D. R. (1998) · Cell · doi:10.1016/s0092-8674(00)81728-6 · Cited by 1,196
Reed, J. C. (1998) · Oncogene · doi:10.1038/sj.onc.1202591 · Cited by 1,049
Korsmeyer, S. J., Wei, M. C., Saito, M., Weiler, S., Oh, K. J., & Schlesinger, P. H. (2000) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400783 · Cited by 1,034
The inhibitors of apoptosis (IAPs) and their emerging role in cancer
LaCasse, E. C., Baird, S., Korneluk, R. G., & MacKenzie, A. E. (1998) · Oncogene · doi:10.1038/sj.onc.1202569 · Cited by 982
Narita, M., Shimizu, S., Ito, T., Chittenden, T., Lutz, R. J., Matsuda, H., & Tsujimoto, Y. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14681 · Cited by 933
Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism
Wong, G. H. W., & Goeddel, D. V. (1988) · Science · doi:10.1126/science.3263703 · Cited by 914
Nagata, S. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4834 · Cited by 905
Bcl-xL forms an ion channel in synthetic lipid membranes
Minn, A. J., Vélez, P., Schendel, S. L., Liang, H., Muchmore, S. W., Fesik, S. W., Fill, M., & Thompson, C. B. (1997) · Nature · doi:10.1038/385353a0 · Cited by 815
Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53
Hoffman, W. H., Biade, S., Zilfou, J. T., Chen, J., & Murphy, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106643200 · Cited by 794
Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling
De Smaele, E., Zazzeroni, F., Papa, S., Nguyen, D. U., Jin, R., Jones, J., Cong, R., & Franzoso, G. (2001) · Nature · doi:10.1038/35104560 · Cited by 732
Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer.
Kawasaki, H., Altieri, D. C., Lu, C., Toyoda, M., Tenjo, T., & Tanigawa, N. (1998) · PubMed · Cited by 706
Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases
Jäättelä, M., Wissing, D., Kokholm, K., Kallunki, T., & Egeblad, M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.21.6124 · Cited by 678
Regulation of apoptosis at cell division by p34 cdc2 phosphorylation of survivin
O'Connor, D. S., Grossman, D., Plescia, J., Li, F., Zhang, H., Villa, A., Tognin, S., Marchisio, P. C., & Altieri, D. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240390697 · Cited by 611
Channel formation by antiapoptotic protein Bcl-2
Schendel, S. L., Xie, Z., Montal, M. O., Matsuyama, S., Montal, M., & Reed, J. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5113 · Cited by 602
Differential Modulation of Apoptosis Sensitivity in CD95 Type I and Type II Cells
Scaffidi, C., Schmitz, I., Zha, J., Korsmeyer, S. J., Krammer, P. H., & Peter, M. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22532 · Cited by 580
The EGFR as a target for anticancer therapy—focus on cetuximab
Baselga, J. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00233-7 · Cited by 563
Expression of survivin and its relationship to loss of apoptosis in breast carcinomas
田中, 慶. (2000) · Medical Entomology and Zoology · doi:10.11501/3179364 · Cited by 559
Moasser, M. M., Basso, A., Averbuch, S. D., & Rosen, N. X. (2001) · PubMed · Cited by 555
Bcl-X L interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation
Hu, Y., Benedict, M. A., Wu, D., Inohara, N., & Núñez, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4386 · Cited by 529
Akt Regulates Cell Survival and Apoptosis at a Postmitochondrial Level
Zhou, H., Li, X.-M., Meinkoth, J., & Pittman, R. N. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.3.483 · Cited by 511
Lu, C., Altieri, D. C., & Tanigawa, N. (1998) · PubMed · Cited by 501
HSP27 inhibits cytochrome c‐dependent activation of procaspase‐9
Garrido, C., Bruey, J., Fromentin, A., Hammann, A., Patrick Arrigo, A., & Solary, E. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.14.2061 · Cited by 500
Olie, R. A., Simões‐Wüst, A. P., Baumann, B., Leech, S. H., Fabbro, D., Stahel, R. A., & Zangemeister‐Wittke, U. (2000) · PubMed · Cited by 489
Chemosensitisation of malignant melanoma by BCL2 antisense therapy
Jansen, B., Wacheck, V, Heere-Ress, E., Schlagbauer-Wadl, H., Hoeller, C., Lucas, T., Hoermann, M., Hollenstein, U., Wolff, K., & Pehamberger, H. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03207-4 · Cited by 482
Bax and Bak Coalesce into Novel Mitochondria-Associated Clusters during Apoptosis
Nechushtan, A., Smith, C. L., Lamensdorf, I., Yoon, S.-H., & Youle, R. J. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.6.1265 · Cited by 477
BAX-dependent transport of cytochrome c reconstituted in pure liposomes
Saito, M., Korsmeyer, S. J., & Schlesinger, P. H. (2000) · Nature Cell Biology · doi:10.1038/35019596 · Cited by 446
Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation
Sahara, S., Aoto, M., Eguchi, Y., Imamoto, N., Yoneda, Y., & Tsujimoto, Y. (1999) · Nature · doi:10.1038/43678 · Cited by 429
Suliman, A., Lam, A., Datta, R., & Srivastava, R. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204282 · Cited by 419
Nylandsted, J., Rohde, M., Brand, K., Bastholm, L., Elling, F., & Jäättelä, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.7871 · Cited by 393
Cuello, M. A., Ettenberg, S. A., Clark, A. S., Keane, M., Posner, R. H., Nau, M. M., Dennis, P. A., & Lipkowitz, S. (2001) · PubMed · Cited by 370
Essential Role of Voltage-Dependent Anion Channel in Various Forms of Apoptosis in Mammalian Cells
Shimizu, S., Matsuoka, Y., Shinohara, Y., Yoneda, Y., & Tsujimoto, Y. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.2.237 · Cited by 367
Cancer gene therapy using a survivin mutant adenovirus
Mesri, M., Wall, N. R., Li, J., Kim, R. W., & Altieri, D. C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12983 · Cited by 337
Self-citationVDAC regulation by the Bcl-2 family of proteins
Tsujimoto, Y., & Shimizu, S. (2000) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400780 · Cited by 337
Yang, X. H., Sladek, T. L., Liu, X., Butler, B. R., Froelich, C. J., & Thor, A. D. (2001) · PubMed · Cited by 299
Inhibition of melanoma tumor growth in vivo by survivin targeting
Grossman, D., Kim, P. J., Schechner, J. S., & Altieri, D. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.635 · Cited by 286
Dong, L., Wang, W., Wang, F., Stoner, M., Reed, J. C., Harigai, M., Samudio, I., Kladde, M. P., Vyhlidal, C., & Safe, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32099 · Cited by 259
Apoptosis in the absence of caspase 3
Liang, Y., Yan, C., & Schor, N. F. (2001) · Oncogene · doi:10.1038/sj.onc.1204815 · Cited by 235
Fulda, S., Meyer, E., Friesen, C., Susin, S. A., Kroemer, G., & Debatin, K.-M. (2001) · Oncogene · doi:10.1038/sj.onc.1204141 · Cited by 223
Structural basis for the activation of human procaspase-7
Riedl, S. J., Fuentes-Prior, P., Renatus, M., Kairies, N., Krapp, S., Huber, R., Salvesen, G. S., & Bode, W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221580098 · Cited by 220
Overexpression of Akt/AKT can modulate chemotherapy-induced apoptosis.
Page, C., Lin, H., Jin, Y. H., et al. (2000) · PubMed · Cited by 220
BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway
Strobel, T., Swanson, L., Korsmeyer, S., & Cannistra, S. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14094 · Cited by 216
Olopade, O. I., Adeyanju, M., Safa, A. R., Hagos, F., Mick, R., Thompson, C. B., & Recant, W. M. (1997) · PubMed · Cited by 203
Perkins, C. L., Fang, G., Kim, C. N., & Bhalla, K. N. (2000) · PubMed · Cited by 203
Seimiya, H., Mashima, T., Toho, M., & Tsuruo, T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4631 · Cited by 201
Anderson, N. G., Ahmad, T., Chan, K., Dobson, R., & Bundred, N. J. (2001) · International Journal of Cancer · doi:10.1002/ijc.1557 · Cited by 197
Overexpression of Bcl-XS sensitizes MCF-7 cells to chemotherapy-induced apoptosis.
Sumantran, V. N., Ealovega, M. W., Núñez, G., Clarke, M. F., & Wicha, M. S. (1995) · PubMed · Cited by 195
Ferreira, C. G., Tolis, C., & Giaccone, G. (1999) · Annals of Oncology · doi:10.1023/a:1008361818480 · Cited by 174
Trauzold, A., Wermann, H., Arlt, A., Schütze, S., Schäfer, H., Oestern, S., Röder, C., Ungefroren, H., Lampe, E., Heinrich, M., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204559 · Cited by 168
A Role for Mitochondrial Bak in Apoptotic Response to Anticancer Drugs
Wang, G.-Q., Gastman, B., Wieckowski, E. U., Goldstein, L. A., Gambotto, A. A., Kim, T., Fang, B., Rabinovitz, A., Yin, X., & Rabinowich, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103526200 · Cited by 135
Nomura, M., Shimizu, S., Ito, T., Narita, M., Matsuda, H., & Tsujimoto, Y. (1999) · PubMed · Cited by 131
Inhibition of the NF-κB transcription factor increases Bax expression in cancer cell lines
Bentires‐Alj, M., Dejardin, E., Viatour, P., Lint, C. M. V., Froesch, B. A., Reed, J. C., Merville, M., & Bours, V. (2001) · Oncogene · doi:10.1038/sj.onc.1204343 · Cited by 125
Javelaud, D., & Besançon, F. (2001) · Oncogene · doi:10.1038/sj.onc.1204570 · Cited by 125
Friedrich, K., Wieder, T., von Haefen, C., Radetzki, S., Jänicke, R. U., Schulze‐Osthoff, K., Dörken, B., & Daniel, P. T. (2001) · Oncogene · doi:10.1038/sj.onc.1204342 · Cited by 122
BID-dependent and BID-independent pathways for BAX insertion into mitochondria
Ruffolo, S. C., Breckenridge, D. G., Nguyen, M., Goping, I. S., Gross, A., Korsmeyer, S. J., Li, H., Yuan, J., & Shore, G. C. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400739 · Cited by 109
Nakashio, A., Fujita, N., Rokudai, S., Sato, S., & TSURUO, T. (2000) · PubMed · Cited by 96
Determinants of the Nuclear Localization of the Heterodimeric DNA Fragmentation Factor (Icad/Cad)
Lechardeur, D., Drzymala, L., Sharma, M., Zylka, D., Kinach, R., Pacia, J., Hicks, C. M., Usmani, N., Rommens, J. M., & Lukács, G. L. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.2.321 · Cited by 87
NF-κB–mediated chemoresistance in breast cancer cells
Weldon, C. B., Burow, M. E., Rolfe, K. W., Clayton, J. L., Jaffe, B. M., & Beckman, B. S. (2001) · Surgery · doi:10.1067/msy.2001.115512 · Cited by 81
Ikeguchi, M., Liu, J., & Kaibara, N. (2002) · APOPTOSIS · doi:10.1023/a:1013556727182 · Cited by 74
Participation of Survivin in mitotic and apoptotic activities of normal and tumor‐derived cells*
Jiang, X., Wilford, C. E., Duensing, S., Münger, K., Jones, G., & Jones, D. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1228 · Cited by 69
Kallio, M. J., Nieminen, M., & Eriksson, J. (2001) · The FASEB Journal · doi:10.1096/fj.01-0280fje · Cited by 69
Jazirehi, A. R., Ng, C., Gan, X.-H., Schiller, G. J., & Bonavida, B. (2001) · PubMed · Cited by 64
Huang, Y., & Fan, W. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.1.105 · Cited by 63
BAD partly reverses paclitaxel resistance in human ovarian cancer cells
Ströbel, T., Tai, Y., Korsmeyer, S. J., & Cannistra, S. A. (1998) · Oncogene · doi:10.1038/sj.onc.1202180 · Cited by 37
Spalding, A. C., Jotte, R. M., Scheinman, R. I., Geraci, M. W., Clarke, P., Tyler, K. L., & Johnson, G. L. (2002) · Oncogene · doi:10.1038/sj.onc.1205048 · Cited by 35
Habraken, Y., Piret, B., & Piette, J. G. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00709-2 · Cited by 24
Kim, R., Ohi, Y., Inoue, H., & Toge, T. (1999) · International Journal of Oncology · doi:10.3892/ijo.15.4.751 · Cited by 15
Self-citation
Cited by
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,778
PI3K/Akt and apoptosis: size matters
Franke, T. F., Hornik, C. P., Segev, L., Shostak, G. A., & Sugimoto, C. (2003) · Oncogene · doi:10.1038/sj.onc.1207115 · Cited by 1,184
Dawidczyk, C. M., Kim, C., Park, J. H., Russell, L. M., Lee, K. H., Pomper, M. G., & Searson, P. C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.036 · Cited by 527
Anticancer therapy targeting the apoptotic pathway
Hu, W., & Kavanagh, J. J. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01277-4 · Cited by 510
The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
Zhou, J., Kang, Y., Chen, L., Wang, H., Liu, J., Zeng, S., & Yu, L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00343 · Cited by 479
Metadata
- Authors
- Kim, R., Tanabe, K., Uchida, Y., Emi, M., Inoue, H., & Toge, T.
- Venue
- Cancer Chemotherapy and Pharmacology
- Published
- 2002-11-01
- Volume
- 50
- Issue
- 5
- Pages
- 343-352
- ISSN
- 0344-5704 (ISSN-L)
- 1432-0843
- OpenAlex
- W51229851
- Cited by
- 253
- References
- 83
- FWCI
- 7.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.